Putting Science to Work


Gregory holds Ph.D. in Organic Chemistry from the University of California, Los Angeles and did his postdoctoral work in Organic Synthesis at Stanford University. He has over 20 years of experience in the area of chemistry and has held key positions at various global organizations including AstraZeneca and Bristol-Myers Squibb. At BMS, Greg led projects in the development of the anti- hepatitis B virus nucleoside analog entecavir, launched in 2004 under the trade name Baraclude. He has authored or co- authored more than 40 peer reviewed chemistry and medicinal chemistry journals, articles and book chapters, and is inventor on 37 patents. Prior to joining Syngene in 2015, Greg worked with AstraZeneca as Associate Director.

People: Management Team

Name: Gregory Bisacchi Ph.D

Position: Global Head - Integrated Drug Discovery

Display Order: 106

This site is best viewed in Firefox (29+), Chrome (35+), or Microsoft Internet Explorer (9+)

Social Widget